On Monday, Shares of Frontier Communications Corp (NASDAQ:FTR), lost -5.40% to $4.73.
Frontier Communications declared its Vice President and Treasurer, John Gianukakis, is planned to present at the Deutsche Bank 2015 Leveraged Finance Conference in Scottsdale, Arizona on Tuesday, September 29, 2015 at 11:40 a.m. Eastern.
Frontier Communications Corporation is a communications company. The Company is engaged in providing services to rural areas and small and medium-sized towns and cities in the United States.
Shares of Twenty-First Century Fox Inc (NASDAQ:FOXA), declined -2.10% to $25.19, during its last trading session.
When Dana Walden and Gary Newman assumed control of the Fox broadcast network in July 2014, their first call was to Ryan Murphy, a creator of “Glee” and “American Horror Story.”
Walden and Newman hoped Murphy would assist them revive a network that once dominated the ratings with “American Idol” and has struggled to find consistent hits since that show’s popularity sagged. With “Scream Queens,” Murphy’s horror comedy that made its debut Tuesday night, they will soon find out if they were right. Bloomberg Reports
“If you want to make a statement, to do a show that feels unique and bold, by and large Ryan is going to deliver that,” Newman said in an interview.
Twenty-First Century Fox, Inc. is a global media and entertainment company. The Company’s Cable Network Programming segment consists of the production and licensing of programming distributed primarily through cable television systems, direct broadcast satellite operators, telecommunication companies and online video distributors.
Shares of Southwestern Energy Company (NYSE:SWN), declined -6.77% to $12.11, during its last trading session, as oil prices were falling due to concerns about a global oversupply of crude.
WTI crude oil for November delivery was down 2.41% to $44.60 a barrel Monday afternoon, and Brent crude oil for November was down 2.33% to $47.47 a barrel.
Despite easing U.S. oil production, output from other counties have kept the global oversupply of crude at more than 1 million barrels a day in the 93 million barrels a day global market, according to the Wall Street Journal.
Southwestern Energy Company is an energy company engaged in natural gas and oil exploration, development and production (E&P). The Company is focused on creating and capturing additional value through its natural gas gathering and marketing businesses, which it refer to as Midstream Services. The Company conducts its business through subsidiaries.
Finally, Endo International (NASDAQ:ENDP), ended its last trade with -10.20% loss, and closed at $61.82.
Endo International declared it has accomplished its formerly declared $8.05 billion acquisition of Par Pharmaceutical Holdings, Inc. from leading global private investment firm TPG.
Through this acquisition, Endo has further established its position as a leading global specialty pharmaceutical company with a fast growing generics business that is among the top five as measured by U.S. sales according to IMS. The acquisition also assists position Endo for long-term double-digit organic growth, improved cash flow generation and raised financial flexibility. Endo’s generics portfolio now comprises an extensive range of in market and R&D stage complex and competitively differentiated dosage forms and delivery systems, with a focus on higher barrier-to-entry and first-to-market products. Endo’s combined U.S. Generics segment, which comprises Par Pharmaceutical and Qualitest, will be named Par Pharmaceutical, an Endo International Company and will be led by Paul Campanelli, former Chief Executive Officer of Par Pharmaceutical, who will also join Endo’s Executive Leadership Team.
In accordance with the terms of the merger agreement, the purchase price comprises of about 18 million shares of Endo equity and $6.50 billion in cash consideration to former Par shareholders. The transaction was financed by a combination of cash, debt and proceeds from a $2.3 billion equity offering accomplished in June 2015.
Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The U.S.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
